Tenet Healthcare beats by $0.61, beats on revs; guides Q2 EPS in-line, revs in-line; guides FY18 EPS above consensus, revs in-line
- Reports Q1 (Mar) earnings of $0.57 per share, excluding non-recurring items, $0.61 better than the Capital IQ Consensus of ($0.04); revenues fell 2.4% year/year to $4.7 bln vs the $4.56 bln Capital IQ Consensus.
- Co issues in-line guidancefor Q2, sees EPS of $0.15-0.29, excluding non-recurring items, vs. $0.17 Capital IQ Consensus Estimate; sees Q2 revs of $4.475-4.675 bln vs. $4.5 bln Capital IQ Consensus Estimate.
- Co issues guidancefor FY18, sees EPS of $1.36-1.70, excluding non-recurring items, vs. $0.92 Capital IQ Consensus Estimate; sees FY18 revs of $17.9-18.3 bln vs. $18.06 bln Capital IQ Consensus Estimate.
No comments:
Post a Comment